• According to a co-author of the study that documented the usage of the robot scientist, Professor Steve Oliver from the University of Cambridge department of biochemistry, by doing this the robot, called Eve, can eliminate the use of toxic compounds in drug candidates and identify elements that can treat disease.
  • Eve exploits artificial intelligence to learn from early successes in her screens and select compounds that have a high probability of being active against a chosen drug target.
  • Screening chemicals at such a dramatically increased rate allows labs to perform more tests, use space and equipment allocated for this purpose more efficiently, and hence discover drugs at a lower cost. The study was able to discover drug candidates that can treat malaria and tropical diseases that haven’t been addressed.

Share This Article